Erratum: Drug pipeline: 2Q15

Nat. Biotechnol. 33, 795 (2015); published online 7 August 2015; corrected after print 6 October 2015

In the version of this article initially published, in the “Notable clinical trial results (2Q 2015)” table, clinical trial data for the drug Glembatumumab vedotin was said to be phase 3. It was phase 2, not phase 3, data. The error has been corrected in the HTML and PDF versions of the article.

Additional information

The online version of the original article can be found at 10.1038/nbt.3312

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark